Thymalin is an immunomodulator polypeptide derived from the thymus gland. Its effectiveness was confirmed in a 2002 study, which concluded that…

“The obtained results convincingly confirmed the ability of the bioregulators to normalize the basic functions of the human organism, i.e. to improve the indices of the cardiovascular, endocrine, immune, and nervous systems, homeostasis, and metabolism.”

In another 2003 study involving 266 elderly people over the age of 60, 2-3 years of treatment with Thymalin was shown to reduce all cause mortality over a timeframe of 6-8 years by a factor of two. Application of the bioregulators over a 3 year time frame showed increased liver detoxification function and intensified bone tissue density over the subsequent 5 year observation period.